Congruence Therapeutics logo

Congruence Therapeutics jobs and careers

Montréal, Canada

About Congruence Therapeutics

Congruence Therapeutics operates as a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding.

Founded
2021
Employees
11 to 50
Total funding
$64.6M
Headquarters
Montréal

Leadership

The top of Congruence Therapeutics's org chart, with how many people report into each leader.

KBPhoto of Katherine Bonter

Katherine Bonter

Executive Director IP and Founder